United Kingdom===National Institute for Health and Care Excellence
Tracked across 3 events · 22 articles · First seen Feb 16, 2026 · Last active Apr 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
The United Kingdom===National Institute for Health and Care Excellence initially rejected zanidatamab for widespread NHS use, causing disappointment among patients and advocates. They are set to reassess the evidence in March, which could lead to a revised recommendation.
Mar 06, 2026 · 7 articles
Regulatory
The United Kingdom===National Institute for Health and Care Excellence has approved the use of semaglutide for overweight and obese patients with specific heart and circulatory problems, which is a significant regulatory decision that will expand the drug's use within the United Kingdom===National Health Service.
Mar 31, 2026 · 8 articles
Regulatory
The United Kingdom===National Institute for Health and Care Excellence will offer guidance to successful applicants, assisting them with regulatory compliance for their new technologies.
Feb 16, 2026 · 7 articles
NEWSDESK
Track United Kingdom===National Institute for Health and Care Excellence live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard